Two global chemicals and coatings giants have signaled their intent to exit the pharmaceuticals segment, as BASF AG announced a deal to sell its pharma operations to Abbott Laboratories, and DuPont said it will seek to divest its pharmaceuticals operations.
BASF, saying it plans to focus on its core chemicals businesses, announced an agreement to sell its pharmaceuticals operations to Abbott Laboratories of the United States for $6.9 billion.